• Events
    • OIS@ASRS 2018
    • OIS@AAO 2018
    • Past Events
    • Hall of Fame
    • Advisory Board
  • News
  • OIS Index
  • Videos
  • Podcast
  • Get Involved
    • Sponsorship Opportunities
    • Presenting Companies
    • Companies to Watch
    • Media & Press
    • Advertise With OIS
    • Be Our Podcast Guest
  • Register

Keyword: Diabetic Retinopathy

How Regeneron Aims to Stay on Message With VR/AR APP

How Regeneron Aims to Stay on Message With VR/AR APP

Virtual reality has been used to train surgeons, to evaluate balance control and associated fall risk in glaucoma patients, and, more recently, to create simulations that allow users to better understand the visual ...

Read More

March 29, 2017 By Steve Lenier

Alimera Sciences: Addressing DME with Persistent Microdose Therapy

Alimera Sciences: Addressing DME with Persistent Microdose Therapy

Alimera Sciences is focused on the commercialization of ILUVIEN (fluocinolone acetonide intravitreal implant) for diabetic macular edema (DME), which received FDA approval in 2014. The product is currently marketed in ...

Play Video

August 29, 2016

Regeneron: Pursuing Combination Therapies with PDGFR-beta and Ang2

Regeneron: Pursuing Combination Therapies with PDGFR-beta and Ang2

Regeneron Pharmaceuticals Inc. markets the highly successful anti-VEGF injection EYLEA (aflibercept), which is FDA approved for neovascular (wet) age-related macular degeneration (AMD), macular edema following retinal ...

Play Video

August 29, 2016

Google–Moorfields Venture Eyes AI to Speed Diagnosis with OCT

Google–Moorfields Venture Eyes AI to Speed Diagnosis with OCT

Google’s DeepMind Health artificial intelligence project and Moorfields Eye Hospital in London have teamed up for a five-year venture to develop an algorithm using one million anonymized retina scans from the Moorfields’ ...

Read More

July 26, 2016 By Howard Wolinksy

Exploring the Keys to Combination Therapies in Retina

Exploring the Keys to Combination Therapies in Retina

The keys to developing combination therapies to treat retinal diseases lie in clinicians being able to better identify biomarkers for disease progression, developing strategies for staging disease, and finding a place ...

Read More

February 3, 2016 By Richard Mark Kirkner

Google Lens Clinical Trials to Start in 2016

Google Lens Clinical Trials to Start in 2016

Novartis, through its Alcon eye-care division, intends to start clinical trials of an accommodative Google “smart” contact lens in human eyes next year, Novartis Chief Executive Joe Jimenez told the Swiss French-language ...

Read More

September 17, 2015 By Richard Mark Kirkner

Is pSivida on the verge of megastar status?

Is pSivida on the verge of megastar status?

With three of the four sustained-release drug delivery products commercially available in the U.S. and Europe, pSivida just might prove Wall Street pundits correct and score some big wins in the ophthalmic space. The ...

Read More

July 30, 2015 By Michelle Dalton

STAY UP TO DATE WITH OIS!

Get the latest news, podcasts and videos. Subscribe Today!

Subscribe Today

Keywords

Allergy AMD Biopharma Brand Drugs Cataract Collaboration Cornea Diabetic Macular Edema Diabetic Retinopathy Diagnostics Digital Ophthalmology Drug Delivery Dry Eye EMR/EHR FDA Financing Gene Therapy Glaucoma Implantable Inlays Innovation IOL IPO Lasers M&A Medicare Medtech MIGS Mobile Apps NEI Ocular Oncology Ophthalmologists Ophthalmology Orphan Drugs Pediatrics Presbyopia R&D Refractive Regulation Retina Stem Cells Surgery Surgical Telemedicine Venture Capital

About OIS
Events
News
Videos
OIS Podcast
OIS Index
Contact Us

Call Us: 516-765-9005

GET INVOLVED

Sponsorship Opportunities
Presenting Companies
Companies to Watch
Media & Press
Advertise with OIS
Be Our Podcast Guest

Upcoming Events

OIS@ASRS 2018
OIS@AAO 2018

Connect With Us

  • Facebook
  • Linkedin
  • Twitter
  • YouTube

© 2018 · Ophthalmology Innovation Summit · Powered by Healthegy · Terms & Conditions · Privacy Policy